11 insiders reported 12 Form 4 transactions for Inhibikase Therapeutics, Inc. (IKT) over the past 18 months (most recent 2026-07-31). Recent activity: BERMAN DENNIS N (Director) Buy 21,854 shares, RA Capital Healthcare Fund LP (10% Owner) Sell 18.0M shares, RA CAPITAL MANAGEMENT, L.P. (10% Owner) Sell 18.0M shares, Kolchinsky Peter (10% Owner) Sell 18.0M shares, Shah Rajeev M. (10% Owner) Sell 18.0M shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-31 | BERMAN DENNIS N | Director | Buy | 21,854 | $27,536 |
| 2026-07-31 | RA Capital Healthcare Fund LP | 10% Owner | Sell | 18.0M | $0 |
| 2026-07-31 | RA CAPITAL MANAGEMENT, L.P. | 10% Owner | Sell | 18.0M | $0 |
| 2026-07-31 | Kolchinsky Peter | 10% Owner | Sell | 18.0M | $0 |
| 2026-07-31 | Shah Rajeev M. | 10% Owner | Sell | 18.0M | $0 |
| 2026-02-24 | Munshi Amit | Director | Sell | 19,089 | $0 |
| 2026-02-24 | Aurentz Vincent | Director | Sell | 255,299 | $0 |
| 2026-02-24 | Cabell Christopher | President & Head of R&D | Sell | 338,282 | $0 |
| 2025-11-24 | Sands Capital Alternatives, LLC | Insider | Buy | 2.1M | $3.0M |
| 2025-11-24 | SANDS FRANK M. | Insider | Buy | 2.1M | $3.0M |
| 2025-11-24 | Sands Capital Life Sciences Pulse Fund II, L.P. | Insider | Buy | 2.1M | $3.0M |
| 2025-08-28 | Munshi Amit | Director | Buy | 57,265 | $0 |
Source: SEC Form 4 filings · as of 2026-07-31